BEAMSTART Logo

China's Abogen Biosciences raises $92m in Series B round

Suzhou Abogen Biosciences has raised as much as 600-million yuan ($92 million) in its Series B round to expand its operation.

  • Suzhou Abogen Biosciences has raised as much as 600-million yuan ($92 million) in its Series B round of funding to expand its operation, per an announcement.
  • The fresh round was jointly led by state-owned investment entities PICC Capital, and SDIC Venture Capital Management, besides YF Capital, a PE firm co-founded by Alibaba’s Jack Ma in 2010.
  • While LYFE Capital and Highlight Capital came in as new investors, the company’s existing backers GL Ventures, TF Capital and Ming Bioventures also topped up in the round.

DEALSTREETASIA.COM12 Apr, 2021

ABOUT THE AUTHOR

Kenneth Ho

Founder & Director @ BEAMSTART. Just launched a VC fund to accelerate awesome startups.

BEAMSTART is a Global Community and News Portal for Entrepreneurship. We cover the latest news and bring together a global network of CEOs/founders, Investors, Business Leaders, and Professionals.

 

Download the Community App

Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities:

PlayStore ButtonAppStore Button

© 2016 - 2021 BEAMSTART. All Rights Reserved (Legal).